BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27739362)

  • 1. Computer-Aided Recognition of ABC Transporters Substrates and Its Application to the Development of New Drugs for Refractory Epilepsy.
    Couyoupetrou M; Gantner ME; Di Ianni ME; Palestro PH; Enrique AV; Gavernet L; Ruiz ME; Pesce G; Bruno-Blanch LE; Talevi A
    Mini Rev Med Chem; 2017; 17(3):205-215. PubMed ID: 27739362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research Progress on the Role of ABC Transporters in the Drug Resistance Mechanism of Intractable Epilepsy.
    Xiong J; Mao DA; Liu LQ
    Biomed Res Int; 2015; 2015():194541. PubMed ID: 26491660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Neuroinflammation on ABC Transporters: Possible Contribution to Refractory Epilepsy.
    Deng X; Xie Y; Chen Y
    CNS Neurol Disord Drug Targets; 2018; 17(10):728-735. PubMed ID: 30152292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABC transporters in drug-resistant epilepsy: mechanisms of upregulation and therapeutic approaches.
    Leandro K; Bicker J; Alves G; Falcão A; Fortuna A
    Pharmacol Res; 2019 Jun; 144():357-376. PubMed ID: 31051235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the possible interaction between anti-epilepsy drugs and multidrug efflux pumps; in vitro observations.
    Rivers F; O'Brien TJ; Callaghan R
    Eur J Pharmacol; 2008 Nov; 598(1-3):1-8. PubMed ID: 18835265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABC Transporters and Drug Resistance in Patients with Epilepsy.
    Feldmann M; Koepp M
    Curr Pharm Des; 2016; 22(38):5793-5807. PubMed ID: 27514707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfunction of ABC Transporters at the Surface of BBB: Potential Implications in Intractable Epilepsy and Applications of Nanotechnology Enabled Drug Delivery.
    Mohi-Ud-Din R; Mir RH; Mir PA; Banday N; Shah AJ; Sawhney G; Bhat MM; Batiha GE; Pottoo FH
    Curr Drug Metab; 2022; 23(9):735-756. PubMed ID: 35980054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
    Lazarowski A; Czornyj L; Lubienieki F; Girardi E; Vazquez S; D'Giano C
    Epilepsia; 2007; 48 Suppl 5():140-9. PubMed ID: 17910594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected.
    Löscher W; Luna-Tortós C; Römermann K; Fedrowitz M
    Curr Pharm Des; 2011; 17(26):2808-28. PubMed ID: 21827408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of ATP-binding cassette transporters at the inner blood-retinal barrier in a neonatal mouse model of oxygen-induced retinopathy.
    Tagami M; Kusuhara S; Honda S; Tsukahara Y; Negi A
    Brain Res; 2009 Aug; 1283():186-93. PubMed ID: 19505448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel approach of targeting refractory epilepsy: Need of an hour.
    Garg N; Joshi R; Medhi B
    Brain Res Bull; 2020 Oct; 163():14-20. PubMed ID: 32679059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ontogeny of ABC and SLC transporters in the microvessels of developing rat brain.
    Soares RV; Do TM; Mabondzo A; Pons G; Chhun S
    Fundam Clin Pharmacol; 2016 Apr; 30(2):107-16. PubMed ID: 26662930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges with the precise prediction of ABC-transporter interactions for improved drug discovery.
    Volpe DA; Qosa H
    Expert Opin Drug Discov; 2018 Aug; 13(8):697-707. PubMed ID: 29943645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RLIP76, a non-ABC transporter, and drug resistance in epilepsy.
    Awasthi S; Hallene KL; Fazio V; Singhal SS; Cucullo L; Awasthi YC; Dini G; Janigro D
    BMC Neurosci; 2005 Sep; 6():61. PubMed ID: 16188027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance.
    Grewal GK; Kukal S; Kanojia N; Saso L; Kukreti S; Kukreti R
    Molecules; 2017 Feb; 22(3):. PubMed ID: 28264441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo experimental models employed in the discovery and development of antiepileptic drugs for pharmacoresistant epilepsy.
    Campos G; Fortuna A; Falcão A; Alves G
    Epilepsy Res; 2018 Oct; 146():63-86. PubMed ID: 30086482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational approaches for innovative antiepileptic drug discovery.
    Talevi A
    Expert Opin Drug Discov; 2016 Oct; 11(10):1001-16. PubMed ID: 27454246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of ABC Transporters in Drug Development.
    Benadiba M; Maor Y
    Curr Pharm Des; 2016; 22(38):5817-5829. PubMed ID: 27514710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioligands targeting P-glycoprotein and other drug efflux proteins at the blood-brain barrier.
    Wanek T; Mairinger S; Langer O
    J Labelled Comp Radiopharm; 2013; 56(3-4):68-77. PubMed ID: 24285312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ABC transporters and drug resistance in epilepsy: biological plausibility, pharmacogenetics and precision medicine].
    Riquelme-Alcázar J; González-Vargas R; Moya PR
    Rev Neurol; 2020 Jan; 70(1):23-32. PubMed ID: 31845753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.